社團法人臺灣臨床藥學會

已出刊文章

【綜合評述】多發性硬化症之藥物治療簡介
Pharmacotherapy of Multiple Sclerosis
多發性硬化症,干擾素β,單株抗體、Multiple Sclerosis, Interferon-β, Monoclonal Antibodies
莊依菁Yi-Ching Chuang* 、蔡佩玲Pei-Ling Tsai 、廖玲巧Lin-Chu Liao
1國立臺灣大學醫學院附設醫院雲林分院藥劑部
多發性硬化症 (multiple sclerosis, MS) 在臺灣被歸類為罕見疾病,但根據衛生福利部中央健康保險署公布的資料統計,在臺灣被確診為多發性硬化症的病人人數逐年不斷攀升。本文將簡單介紹多發性硬化症的分類、症狀及診斷,與目前的治療方式與藥物。
 
Multiple sclerosis (MS) is a rare disease worldwide. According to the database of National Health Insurance Administration Ministry of Health and Welfare, the prevalence of MS has been reported an increasing trend in Taiwan. The objective of this article is to introduce an update information on the epidemiology, types, symptoms and management of multiple sclerosis.
操作進行中,請稍候~~~~
×
加载中...